Myelofibrosis Latest Advances

Managing myelofibrosis in the frailty era: the expanding role of JAK inhibitors.

Journal: Leukemia & lymphoma

Published: April 15, 2026

Myeloproliferative neoplasm as a cause of splanchnic vein thrombosis.

Journal: BMJ case reports

Published: April 14, 2026

Acquired Hemophilia A Associated with Post-Essential Thrombocythemia Myelofibrosis: A Rare Autoimmune Bleeding Complication.

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: April 10, 2026

Platelets Outperform Leukocytes in Transcriptomic Liquid Biopsy Profiling of Myeloproliferative Neoplasms.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

A pharmacological profile of pacritinib for the treatment of myelofibrosis.

Journal: Expert review of clinical pharmacology

Published: April 08, 2026

Combination treatments for myelofibrosis in JAK inhibitor-naive patients: evidence, rationale, and clinical direction.

Journal: Expert opinion on pharmacotherapy

Published: April 01, 2026

CRE26-057: Rare Transformation of JAK2-Positive Primary Myelofibrosis to B-Cell Acute Lymphoblastic Leukemia: A Case Report and Molecular Analysis.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 31, 2026

When Myelofibrosis is Skin-Deep: A Clinical Clue to a Rare Diagnosis.

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: March 27, 2026

Bone Marrow Morphology in Hereditary Thrombocytosis May Show Features of Myeloproliferative Neoplasms: A Case Report of a Child with Homozygous MPL Baltimore Germline Variant and Review of Literature.

Journal: Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society

Published: March 21, 2026

Effect of the Degree of Myelofibrosis on the Therapeutic Efficacy and Survival in Patients with Myelodysplastic Syndromes

Journal: Zhongguo shi yan xue ye xue za zhi

Published: March 18, 2026

Research Progress of Megakaryocyte Morphology in the Prognosis of Primary Myelofibrosis--Review

Journal: Zhongguo shi yan xue ye xue za zhi

Published: March 18, 2026

Paz DL, Gagelmann N, Benajiba L, et al. Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis. Blood Adv. 2025;9(4):797-807.

Journal: Blood advances

Published: March 16, 2026

Myelofibrosis Latest Advances

Find the Latest Research About Myelofibrosis

Managing myelofibrosis in the frailty era: the expanding role of JAK inhibitors.

Managing myelofibrosis in the frailty era: the expanding role of JAK inhibitors.

Myeloproliferative neoplasm as a cause of splanchnic vein thrombosis.

Myeloproliferative neoplasm as a cause of splanchnic vein thrombosis.

Acquired Hemophilia A Associated with Post-Essential Thrombocythemia Myelofibrosis: A Rare Autoimmune Bleeding Complication.

Acquired Hemophilia A Associated with Post-Essential Thrombocythemia Myelofibrosis: A Rare Autoimmune Bleeding Complication.

Platelets Outperform Leukocytes in Transcriptomic Liquid Biopsy Profiling of Myeloproliferative Neoplasms.

Platelets Outperform Leukocytes in Transcriptomic Liquid Biopsy Profiling of Myeloproliferative Neoplasms.

A pharmacological profile of pacritinib for the treatment of myelofibrosis.

A pharmacological profile of pacritinib for the treatment of myelofibrosis.

Combination treatments for myelofibrosis in JAK inhibitor-naive patients: evidence, rationale, and clinical direction.

Combination treatments for myelofibrosis in JAK inhibitor-naive patients: evidence, rationale, and clinical direction.

CRE26-057: Rare Transformation of JAK2-Positive Primary Myelofibrosis to B-Cell Acute Lymphoblastic Leukemia: A Case Report and Molecular Analysis.

CRE26-057: Rare Transformation of JAK2-Positive Primary Myelofibrosis to B-Cell Acute Lymphoblastic Leukemia: A Case Report and Molecular Analysis.

When Myelofibrosis is Skin-Deep: A Clinical Clue to a Rare Diagnosis.

When Myelofibrosis is Skin-Deep: A Clinical Clue to a Rare Diagnosis.

Bone Marrow Morphology in Hereditary Thrombocytosis May Show Features of Myeloproliferative Neoplasms: A Case Report of a Child with Homozygous MPL Baltimore Germline Variant and Review of Literature.

Bone Marrow Morphology in Hereditary Thrombocytosis May Show Features of Myeloproliferative Neoplasms: A Case Report of a Child with Homozygous MPL Baltimore Germline Variant and Review of Literature.

Effect of the Degree of Myelofibrosis on the Therapeutic Efficacy and Survival in Patients with Myelodysplastic Syndromes

Effect of the Degree of Myelofibrosis on the Therapeutic Efficacy and Survival in Patients with Myelodysplastic Syndromes

Research Progress of Megakaryocyte Morphology in the Prognosis of Primary Myelofibrosis--Review

Research Progress of Megakaryocyte Morphology in the Prognosis of Primary Myelofibrosis--Review

Paz DL, Gagelmann N, Benajiba L, et al. Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis. Blood Adv. 2025;9(4):797-807.

Paz DL, Gagelmann N, Benajiba L, et al. Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis. Blood Adv. 2025;9(4):797-807.